Skip to content
Katsuyuki Takeda

Katsuyuki Takeda, MD, is a researcher at National Jewish Health. Dr. Takeda is in the Division of Cell Biology and Department of Pediatrics.



Special Interests


Research Interests

Bronchial asthma; as asthma is the most common chronic inflammatory lung disease, I intend to elucidate the disease mechanisms and explore a new therapeutic approach.

Emphysema; as emphysema is a terminal stage of lung damage in lung diseases such as cigarette smoking-associated COPD or Alpha 1-antitrypsin deficiency, which is a genetic disease. My goal is to explore a novel therapeutic tool to repair and normalize damaged lung tissue.

Education


Education

1993
Okayama Medical School, PhD
1984
Tottori University, MD

Awards & Recognition


1998: Astra Research Grant (Competitive Grant for Asthma Research, Japan)
2010: ATS Grant “Alpha-1 Foundation Research Grant in Alpha-1”

Board Certification


Japanese Society of Internal Medicine 

Professional Memberships


American Thoracic Society (ATS)
Japanese Society of Internal Medicine

Publications


Takeda K, et al. Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation. Immune Netw. 2016;16:165-75.

Takeda K, et al. Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge. J Allergy Clin Immunol. 2015;135:451-460.

Takeda K, et al. The Critical Role of Complement Alternative Pathway Regulator Factor H in Allergen-Induced Airway Hyperresponsiveness and Inflammation. J Immunol. 2012 188:661-7. 9.     

Takeda K, et al. Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation. Br J Pharmacol, 2010, 160:1399-407. 14. 

Takeda K, et al. Vaccine-Induced CD8  T Cell-Dependent Suppression of Airway Hyperresponsiveness and Inflammation. J Immunol. 2009, 183:181-90.

Website Information


Takeda Lab